ArticleCellular oncology (Dordrecht, Netherlands)2025

Synthetic NKG2D receptor (SNR) armored CAR-T cells overcome antigen heterogeneity of solid tumor.

Minmin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.